Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa (HIDRI2007)

This study has been completed.
Sponsor:
Collaborator:
Abbott
Information provided by:
Florida Academic Dermatology Centers
ClinicalTrials.gov Identifier:
NCT00827996
First received: January 21, 2009
Last updated: January 22, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2008
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)